182 related articles for article (PubMed ID: 9139553)
1. Sustained biochemical and histologic remission of primary biliary cirrhosis in response to medical treatment.
Kaplan MM; DeLellis RA; Wolfe HJ
Ann Intern Med; 1997 May; 126(9):682-8. PubMed ID: 9139553
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of colchicine in patients with primary biliary cirrhosis poorly responsive to ursodiol and methotrexate.
Lee YM; Kaplan MM
Am J Gastroenterol; 2003 Jan; 98(1):205-8. PubMed ID: 12526960
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate in patients with primary biliary cirrhosis who respond incompletely to treatment with ursodeoxycholic acid.
Kaplan MM; Bonder A; Ruthazer R; Bonis PA
Dig Dis Sci; 2010 Nov; 55(11):3207-17. PubMed ID: 20559727
[TBL] [Abstract][Full Text] [Related]
4. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis.
Kaplan MM
Semin Liver Dis; 1997 May; 17(2):129-36. PubMed ID: 9170200
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate therapy for the symptomatic treatment of primary biliary cirrhosis patients, who are biochemical incomplete responders to ursodeoxycholic acid therapy.
Babatin MA; Sanai FM; Swain MG
Aliment Pharmacol Ther; 2006 Sep; 24(5):813-20. PubMed ID: 16918885
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial of colchicine plus ursodiol versus methotrexate plus ursodiol in primary biliary cirrhosis: ten-year results.
Kaplan MM; Cheng S; Price LL; Bonis PA
Hepatology; 2004 Apr; 39(4):915-23. PubMed ID: 15057894
[TBL] [Abstract][Full Text] [Related]
7. The combination of ursodeoxycholic acid and methotrexate for primary biliary cirrhosis is not better than ursodeoxycholic acid alone.
González-Koch A; Brahm J; Antezana C; Smok G; Cumsille MA
J Hepatol; 1997 Jul; 27(1):143-9. PubMed ID: 9252088
[TBL] [Abstract][Full Text] [Related]
8. A prospective trial of colchicine and methotrexate in the treatment of primary biliary cirrhosis.
Kaplan MM; Schmid C; Provenzale D; Sharma A; Dickstein G; McKusick A
Gastroenterology; 1999 Nov; 117(5):1173-80. PubMed ID: 10535881
[TBL] [Abstract][Full Text] [Related]
9. Primary biliary cirrhosis.
Gong Y; Christensen E; Gluud C
N Engl J Med; 2005 Dec; 353(25):2719-20; author reply 2719-20. PubMed ID: 16379089
[No Abstract] [Full Text] [Related]
10. Methotrexate improves biochemical tests in patients with primary biliary cirrhosis who respond incompletely to ursodiol.
Bonis PA; Kaplan M
Gastroenterology; 1999 Aug; 117(2):395-9. PubMed ID: 10419921
[TBL] [Abstract][Full Text] [Related]
11. Colchicine for primary biliary cirrhosis.
Gong Y; Gluud C
Cochrane Database Syst Rev; 2004; (2):CD004481. PubMed ID: 15106254
[TBL] [Abstract][Full Text] [Related]
12. Treatment of primary biliary cirrhosis with low-dose weekly methotrexate.
Kaplan MM; Knox TA
Gastroenterology; 1991 Nov; 101(5):1332-8. PubMed ID: 1936805
[TBL] [Abstract][Full Text] [Related]
13. Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
Corpechot C; Abenavoli L; Rabahi N; Chrétien Y; Andréani T; Johanet C; Chazouillères O; Poupon R
Hepatology; 2008 Sep; 48(3):871-7. PubMed ID: 18752324
[TBL] [Abstract][Full Text] [Related]
14. Clinical and biochemical features and therapy responses in primary biliary cirrhosis and primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Günsar F; Akarca US; Ersöz G; Karasu Z; Yüce G; Batur Y
Hepatogastroenterology; 2002; 49(47):1195-200. PubMed ID: 12239904
[TBL] [Abstract][Full Text] [Related]
15. Long-term ursodeoxycholic acid therapy for primary biliary cirrhosis: a follow-up to 12 years.
Chan CW; Gunsar F; Feudjo M; Rigamonti C; Vlachogiannakos J; Carpenter JR; Burroughs AK
Aliment Pharmacol Ther; 2005 Feb; 21(3):217-26. PubMed ID: 15691295
[TBL] [Abstract][Full Text] [Related]
16. Comparison of three doses of ursodeoxycholic acid in the treatment of primary biliary cirrhosis: a randomized trial.
Angulo P; Dickson ER; Therneau TM; Jorgensen RA; Smith C; DeSotel CK; Lange SM; Anderson ML; Mahoney DW; Lindor KD
J Hepatol; 1999 May; 30(5):830-5. PubMed ID: 10365809
[TBL] [Abstract][Full Text] [Related]
17. Reversal of cirrhosis in a patient with primary biliary cirrhosis-autoimmune hepatitis overlap syndrome.
Vallone TM; Ditelberg J; Kaplan MM
Dig Dis Sci; 2005 Jan; 50(1):167-70. PubMed ID: 15712656
[No Abstract] [Full Text] [Related]
18. Effects of additional administration of colchicine in ursodeoxycholic acid-treated patients with primary biliary cirrhosis: a prospective randomized study.
Ikeda T; Tozuka S; Noguchi O; Kobayashi F; Sakamoto S; Marumo F; Sato C
J Hepatol; 1996 Jan; 24(1):88-94. PubMed ID: 8834030
[TBL] [Abstract][Full Text] [Related]
19. [Treatment of primary biliary cirrhosis].
Szalay F
Orv Hetil; 2003 Sep; 144(36):1787-8. PubMed ID: 14579676
[No Abstract] [Full Text] [Related]
20. Triple therapy with ursodeoxycholic acid, budesonide and mycophenolate mofetil in patients with features of severe primary biliary cirrhosis not responding to ursodeoxycholic acid alone.
Rabahi N; Chrétien Y; Gaouar F; Wendum D; Serfaty L; Chazouillères O; Corpechot C; Poupon R
Gastroenterol Clin Biol; 2010; 34(4-5):283-7. PubMed ID: 20417047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]